Haemonetics Corporation (HAE): Price and Financial Metrics

Haemonetics Corporation (HAE): $60.07

1.66 (+2.84%)

POWR Rating

Component Grades














  • HAE scores best on the Value dimension, with a Value rank ahead of 79.81% of US stocks.
  • The strongest trend for HAE is in Growth, which has been heading up over the past 31 weeks.
  • HAE's current lowest rank is in the Quality metric (where it is better than 22.16% of US stocks).

HAE Stock Summary

  • Haemonetics Corp's stock had its IPO on May 10, 1991, making it an older stock than 83.55% of US equities in our set.
  • With a year-over-year growth in debt of 85%, Haemonetics Corp's debt growth rate surpasses 90.09% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for HAE comes in at -12.37% -- higher than that of merely 17.78% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Haemonetics Corp, a group of peers worth examining would be DIOD, ACA, CSGS, AZZ, and HUBG.
  • HAE's SEC filings can be seen here. And to visit Haemonetics Corp's official web site, go to www.haemonetics.com.

HAE Price Target

For more insight on analysts targets of HAE, see our HAE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $81.17 Average Broker Recommendation 1.42 (Moderate Buy)

HAE Stock Price Chart Interactive Chart >

Price chart for HAE

HAE Price/Volume Stats

Current price $60.07 52-week high $142.11
Prev. close $58.41 52-week low $49.26
Day low $58.66 Volume 481,100
Day high $60.08 Avg. volume 742,241
50-day MA $72.63 Dividend yield N/A
200-day MA $101.34 Market Cap 3.06B

Haemonetics Corporation (HAE) Company Bio

Haemonetics designs, manufactures, and markets blood management solutions. The Company serves in three markets, such as manufacturers of plasma-derived pharmaceuticals, blood collectors, and hospitals. The company was founded in 1971 and is based in Braintree, Massachusetts.

HAE Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$60.07$108.9 94%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Haemonetics Corp. To summarize, we found that Haemonetics Corp ranked in the 69th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Haemonetics Corp, consider:

  • Interest coverage, a measure of earnings relative to interest payments, is 9.34; that's higher than 62.43% of US stocks in the Healthcare sector that have positive free cash flow.
  • The company's compound free cash flow growth rate over the past 5.52 years comes in at 0.48%; that's greater than 78.56% of US stocks we're applying DCF forecasting to.
  • 90% of the company's capital comes from equity, which is greater than 71.6% of stocks in our cash flow based forecasting set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Haemonetics Corp? See HCA, ALXN, ANTM, STAA, and IIN.

HAE Latest News Stream

Event/Time News Detail
Loading, please wait...

HAE Latest Social Stream

Loading social stream, please wait...

View Full HAE Social Stream

Latest HAE News From Around the Web

Below are the latest news stories about Haemonetics Corp that investors may wish to consider to help them evaluate HAE as an investment opportunity.

Blood Filter Market 2021 Emerging Technology Rising Global Demand Till 2028 | Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Fresenius Kabi Deutschland GmbH & More

Worldwide Blood Filter Market Analysis to 2028 is a specialized and in-depth study of the Blood Filter Market Industry with a focus on the global market trend. The report aims []

iCrowdNewswire | June 11, 2021

Blood Filter Market 2021 Rising Global Demand by 2028 | Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Fresenius Kabi Deutschland GmbH & More

Worldwide Blood Filter Market Analysis to 2028 is a specialized and in-depth study of the Blood Filter Market Industry with a focus on the global market trend. The report aims to provide an overview of global Blood Filter Market with

OpenPR | June 10, 2021

New Opporunities in Apheresis Market 2021-2025 Strategical Assessment of Asahi Kasei Corporation, B. Braun Melsungen AG, FRESENIUS SE & CO. KGAA (Fresenius Kabi AG), Haemonetics Corporation, Terumo corporation (Terumo BCT), Kaneka Corporation, and more

AllTheResearchs Global Apheresis Market Strategic recommendations, Trends, Segmentation, Use case Analysis, Competitive Intelligence, Global and Regional Forecast (to 2026) report provides an overview of the market size of Apheresis for the regions United States, Europe (France, Germany, Italy, Spain, UK) and Japan, etc. Based on the Apheresis industrial chain, this report mainly elaborates on []

Jumbo News | June 7, 2021

Plasma Collection Systems Market to Develop New Growth Story | Medtronic plc, Sarstedt AG & Co., Haemonetics Corp., FL MEDICAL s.r.l

Plasma collection systems play a crucial role in the patient treatment. Plasma collection systems are used in the treatment of patients suffering from chronic diseases, especially during chemotherapy, dialysis, complex surgeries, and organ or tissue transplantation procedures. Plasma collection systems

OpenPR | June 2, 2021

Coagulation Reagents Market 2021 with (COVID-19) Impact Analysis | likewise Industry is Booming Globaly with Top Players Haemonetics Corporation, Sekisui, Steellex., Randox

Global Coagulation Reagents Market Key Players, Business Approaches And Geographical Analysis Amid COVID-19 Pandemic The report on Coagulation Reagents Market published by Market Research Store Overview By Industry Top Manufactures, Trends, Industry Growth, Size, Analysis & Forecast Till 2028 the report come up with 150+ pages PDF with TOC including a list of figures []

Jumbo News | June 2, 2021

Read More 'HAE' Stories Here

HAE Price Returns

1-mo 7.27%
3-mo -49.64%
6-mo -49.61%
1-year -32.58%
3-year -37.26%
5-year 104.95%
YTD -49.41%
2020 3.35%
2019 14.84%
2018 72.26%
2017 44.48%
2016 24.69%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8099 seconds.